UNSPSC 41131727: Prothrombin-proconvertin test and thrombotest

In this classification a prothrombin-proconvertin test and thrombotest are devices used in the regulation of coumarin therapy (administration of a coumarin anticoagulant such as sodium warfarin in the treatment of venous thrombosis and pulmonary embolism) and as a diagnostic test in conjunction with, or in place of, the Quick prothrombin time test to detect coagulation disorders US FDA regulates Prothrombin-proconvertin test and thrombotest under 21 CFR 864.7735 and under FDA product code JPF.

UNSPSC 41131727 Prothrombin-proconvertin test and thrombotest (Commodity) does not map cleanly to the recent state and local procurement activity tagged under this code. The opportunities posted show substantial activity in drug testing services, laboratory supplies, occupational health screening, and forensic analysis—work that falls outside the clinical coagulation testing scope implied by the code name. State and local governments are procuring offender drug testing services, drug screening supplies, laboratory reference materials, urinalysis testing, occupational medical services, and specialized assay kits, but very little of this activity involves prothrombin-proconvertin or thrombotest procedures as narrowly defined.

The issuing bodies include county community supervision and corrections departments (Collin County, Texas), county health systems (Collin County Health Care Services), county procurement offices (Gwinnett County, Georgia; Benton County, Oregon; Pinellas County, Florida; Seminole County, Florida; Bernalillo County, New Mexico), state comptroller procurement divisions (Texas Comptroller of Public Accounts), state health agencies (State of Oregon), city procurement bureaus (City of Charlotte), and higher-education institutions (University of Wisconsin-Madison). Geographic activity spans Texas, Georgia, Oregon, Florida, New Mexico, Wisconsin, and North Carolina. Representative recent opportunities include Collin County Community Supervision and Corrections Department's RFP for offender specimen collection and drug testing services with an estimated contract value of $600,000 and proposals due July 23, 2026; the Texas Comptroller of Public Accounts' IFB for proprietary chemical laboratory equipment and supplies for DNA analysis and drug screening, with bids due October 20, 2026; and Benton County, Oregon's RFP for urinalysis testing services supporting its Family Treatment Court Program, with proposals due July 7, 2026. The code shows minimal recent activity aligned with its nominal scope of coagulation testing and should likely be monitored for reclassification or re-tagging by issuing agencies.